Digitizing and Optimizing Sustainable Infrastructure

NIST AI RMF Sets Policies and Guidelines That Underpin the Trusted Development of New DistillerSR AI Capabilities for Literature Review Automation

Groundbreaking Study Confirms Fibromyalgia as a True Medical Condition with 100% Accuracy Using Unique DNA Genomic Signatures, Offering New Hope for Objective Diagnosis and Treatment.​

Combining Tanvex’s biosimilar development expertise and U.S. FDA-licensed commercial-scale facility in San Diego, California, with Bora’s extensive global CDMO capabilities, the alliance aims to provide comprehensive solutions to biologics CDMO customers around the world.

The Collaboration Aims to Address The Unmet Clinical Challenge Of Compromised Vision In Surgery

NASH kNOWledge redesigns website; introduces new URL as 6-year anniversary approaches

Protecting patients’ rights and safety in Clinical Trial enrollment

FDA Approval of Nypozi™ and FDA BLA Acceptance of TX-05 Further Validates Tanvex's Expertise in Biologics Development and Manufacturing.

-Super Speed of Only Nine Months

Prognos Health, the recognized leader in lab-based precision marketing solutions, today announced the launch of its daily HCP alerts solution for select conditions.

Leapcure enhances clinical trials and affordable patient recruitment with strategic acquisition of Honeybee Trials.

Transforming Pharmaceutical Supply Chains for DSCSA Readiness

The study raises concerns that overprescribing medications and the resulting unused medication are drivers of opioid misuse.

Proven track record of consistent high quality confirmed at Pace® Life Sciences headquarters

Bornilla brings over 25 years of commercial pharmaceutical experience to Pace®

Maryland-based biotechnology leader, Elixirgen Scientific, Inc., launches Alzheimer’s Disease Panel, strengthening their commitment to quality and innovation in disease research and drug discovery.

Established Canadian online pharmacy now partnering with smaller pharmacies

Exploring Mission Hill Foods' Pursuit of Excellence in Nutrition and Environmental Responsibility

Presented at Respiratory Drug Delivery 2024, the Nasdepi Canine Study Indicates the Dry Powder Nasal Solution Provides a Faster and More Effective Treatment for Anaphylaxis as a Result of Severe Allergies

Scailyte appoints Tim Foley as Chief Business Officer, Jean-Pierre Rosat as Executive Chair, and Darrin Crisitello as member of the BoD

Lifesciences Magazine: Battling Diabetes! Exclusive Interview with the Glen Travers (Co-founder of Diabetology Limited), Leading Biopharma Company Pushing Boundaries

GB Sciences’ Licensing Deal with Endopure Life Sciences will also include Rights to Develop and Market GB Sciences’ Cannabinoid-based Treatments for a Suite of Neurological Disorders

Companies Form Expert Working Group to Introduce Essential Tools for AAV Development and Research Professionals

The first-in-class GenAI Platform Dante GenomeChat was presented to a private audience at Amazon Web Services Health Summit in Amsterdam, showcasing how it leverages billions of parameters and Dante Genomics expertise to provide doctors with prioritised and personalized insights

Enhancement Streamlines Chemical Data Management with Accurate and Automated IUPAC Naming

Vivian joins Faro Health Inc. as the company aims to accelerate the growth and adoption of its market-leading SaaS platform for data-driven clinical development.

$400,000 award will support characterization and efficacy testing of preclinical SR-03 cell line as a part of IND development. Seraxis is taking meetings at the American Diabetes Association Annual Meeting in Orlando, June 21-24.